CNA FINANCIAL CORP annual report, FY2019

CNA Financial Corporation — 2019 Form 10-K

Business context and reporting period. This annual report covers the year ended December 31, 2019; quarterly figures are unaudited. CNA is a commercial property and casualty insurer with Specialty, Commercial and International operations, plus a run-off Life & Group business that primarily consists of long-term care policies. Loews Corporation owned approximately 89% of CNA at year-end.

Financial performance and condition

Metric20192018
Total revenue$10.767 billion$10.134 billion
Net income$1.000 billion$813 million
Diluted earnings per share$3.67$2.98
Core income (non-GAAP)$979 million$845 million
Net earned premiums$7.428 billion$7.312 billion
Net investment income$2.118 billion$1.817 billion
Net cash from operating activities$1.140 billion$1.227 billion
Total investments$47.744 billion$44.486 billion
Long-term debt$2.679 billion$2.680 billion
Stockholders’ equity$12.215 billion$11.217 billion
Book value per common share$45.00$41.32
  • 2019 total revenue included $29 million of net investment gains, compared with a $52 million net investment loss in 2018. Core income excludes investment gains and losses and other specified items.
  • Property and casualty combined ratios were 90.2% for Specialty (88.2% in 2018), 100.8% for Commercial (101.1%) and 101.8% for International (106.5%). A ratio below 100% indicates underwriting profit before investment income.
  • Net catastrophe losses declined to $179 million from $252 million. Favorable prior-year P&C reserve development was $73 million, versus $181 million in 2018.
  • Cash and short-term investments were $2.103 billion at year-end. CNA reported no borrowings under its $250 million revolving credit facility. Operating cash flow fell year over year, reflecting a pension contribution, lower limited-partnership distributions and higher claim payments, partly offset by increased premiums collected.
  • Common dividends paid totaled $929 million; the 2019 declared dividend was $3.40 per share, including a $2.00 special dividend. In February 2020, the board declared a further $2.00 special dividend and a $0.37 quarterly dividend.

Material changes versus the prior comparable period

  • Net income rose to $1.000 billion from $813 million, and core income increased to $979 million from $845 million. Higher investment income—especially returns from limited partnerships and common stocks—and stronger current-year P&C underwriting contributed to the improvement.
  • Life & Group core results moved to a $109 million loss from $43 million of income. A $170 million charge followed the 2019 long-term care gross premium valuation, which identified a $216 million pretax premium deficiency; lower-than-expected claim severity partly offset the charge.
  • International core results improved to $30 million from a $19 million loss, while premiums declined amid foreign-exchange effects and Hardy’s exit from certain business classes. Commercial and Specialty premiums increased.
  • Net investment income increased by $301 million, including a substantial improvement in limited-partnership and common-stock returns. Net unrealized investment gains also lifted other comprehensive income; year-end AOCI improved from a loss of $878 million to income of $51 million.
  • Reported warranty revenue and expense are affected by the accounting treatment adopted in 2018, which grosses up revenue and expense and recognizes them over time. This affects year-over-year comparability of those line items.
  • CNA issued $500 million of 3.90% senior notes due 2029 and redeemed $500 million of 5.875% notes due 2020. Total debt was broadly unchanged.

Outlook, risks and unusual items

  • CNA gave no specific earnings or revenue guidance. Management stated it believes current cash flows are sufficient for expected working-capital and debt needs in the near term.
  • Long-term care assumptions are a major uncertainty. The 2019 reserve deficiency was driven primarily by lower expected reinvestment rates and revised persistency assumptions, partly offset by premium-rate actions and favorable morbidity and expense assumptions. The filing’s sensitivity analysis shows material potential pretax income effects from changes in morbidity, persistency, discount rates or approved premium increases; the next annual valuation was expected in the third quarter of 2020.
  • Management identifies P&C reserve estimates—particularly long-tail professional and management liability, workers’ compensation and general liability—as sensitive to severity, inflation, legal developments and claims experience. Illustrative sensitivities include approximately $400 million of higher net reserves from a 9% increase in severity for certain professional, management liability and surety products, and approximately $350 million from a 100-basis-point increase in workers’ compensation claim-cost inflation.
  • Legacy asbestos and environmental pollution liabilities remain a risk. The NICO loss portfolio transfer has a $4 billion aggregate limit; $3.2 billion had been ceded cumulatively by year-end 2019. CNA reported $150 million of gross adverse A&EP reserve development before the transfer in 2019, partly offset by the deferred retroactive reinsurance benefit. NICO’s collateral trust was valued at $3.7 billion, and Berkshire Hathaway guarantees specified obligations.
  • Other principal risks include catastrophe losses, mass tort and emerging claims, reinsurance and policyholder collectibility, investment-market volatility, regulation and capital requirements, cyber and operational disruption, and competition. TRIPRA’s federal terrorism backstop was extended through 2027, subject to program terms and limits.
  • CCC’s statutory capital and surplus was approximately 291% of company-action-level risk-based capital at year-end. Insurance-subsidiary dividends are regulated and are an important source of cash for the holding company. CNA’s major rating agencies reported stable outlooks; S&P and A.M. Best upgraded specified ratings in 2019.
  • The auditor issued unqualified opinions on the financial statements and internal control over financial reporting. Property and casualty reserves and long-term care future policy benefit reserves were identified as critical audit matters because of the judgment and uncertainty involved.

Important facts for investors to verify

  • Whether long-term care claims, persistency, discount rates and approved premium increases support the assumptions underlying the $12.3 billion of gross future policy benefit reserves.
  • Whether current and future P&C reserve development, especially general liability, professional liability and workers’ compensation, remains consistent with management’s estimates.
  • The remaining capacity and collectibility of the NICO A&EP transfer, including exposure to claims outside its terms or above its limit.
  • How much 2019 earnings growth reflects repeatable underwriting and investment performance versus variable limited-partnership and common-stock returns.
  • The sustainability of dividends and special distributions given holding-company reliance on regulated subsidiary dividends and substantial insurance obligations.
  • Warranty revenue comparability and future cash-flow conversion, given deferred warranty revenue of $3.8 billion and deferred acquisition costs of $2.8 billion at year-end.